Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neurons
- PMID: 6141617
- DOI: 10.1016/0278-5846(83)90062-3
Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neurons
Abstract
The classical neuroleptics haloperidol, perphenazine and chlorpromazine increase both dopamine metabolism and release in the mouse striatum. The atypical agents clozapine and thioridazine increase dopamine metabolism with no increase in release. At high doses, sulpiride increases both dopamine metabolism and release. These data suggest that atypical neuroleptics act to inhibit dopamine release and indicate that sulpiride may not be an atypical agent.
Similar articles
-
The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatum.Neuropharmacology. 1982 Jun;21(6):529-37. doi: 10.1016/0028-3908(82)90043-0. Neuropharmacology. 1982. PMID: 6125910
-
Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.Synapse. 1990;6(1):1-9. doi: 10.1002/syn.890060102. Synapse. 1990. PMID: 1697986
-
Use of amfonelic acid to discriminate between classical and atypical neuroleptics and neurotensin: an in vivo voltammetric study.Brain Res. 1991 Mar 22;544(1):86-93. doi: 10.1016/0006-8993(91)90888-3. Brain Res. 1991. PMID: 1677303
-
[Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].Farmakol Toksikol. 1982 Sep-Oct;45(5):118-26. Farmakol Toksikol. 1982. PMID: 6128251 Review. Russian. No abstract available.
-
Progesterone action on the LHRH and the nigrostriatal dopamine neuronal systems: in vitro and in vivo studies.Recent Prog Horm Res. 1985;41:421-72. doi: 10.1016/b978-0-12-571141-8.50014-7. Recent Prog Horm Res. 1985. PMID: 2996091 Review. No abstract available.
Cited by
-
Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.Br J Pharmacol. 1992 Mar;105(3):703-7. doi: 10.1111/j.1476-5381.1992.tb09042.x. Br J Pharmacol. 1992. PMID: 1628156 Free PMC article.
-
Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.J Neural Transm (Vienna). 1996;103(7):777-805. doi: 10.1007/BF01273358. J Neural Transm (Vienna). 1996. PMID: 8872864 Review.
-
Mechanisms of action of atypical antipsychotic drugs: a critical analysis.Psychopharmacology (Berl). 1996 Mar;124(1-2):2-34. doi: 10.1007/BF02245602. Psychopharmacology (Berl). 1996. PMID: 8935797 Review.
-
Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.Naunyn Schmiedebergs Arch Pharmacol. 1988 Aug;338(2):162-8. doi: 10.1007/BF00174864. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2903451